jRCT2071240021进行中(未招募)不适用
Clinical pharmacology study to evaluate the effects of food on TAS-115 in healthy subjects
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 32
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Crossover Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 40age old not(—)
- 性别
- Male
入选标准
- •(1) Provided written informed consent
- •(2) Men aged 18 or older and younger than 40 years at the time of consent
- •(3) Weigh at least 50.0 kg at the time of screening tests with a body mass index (BMI, weight [kg]/[height {m}]2) ranging from 18.5 to < 25.0 kg/m2
- •(4) Vital signs obtained in screening tests within the following ranges
- •a) Systolic blood pressure (in supine position), 90 to 139 mmHg
- •b) Diastolic blood pressure (in supine position), 40 to 89 mmHg
- •c) Pulse rate ranging from 40 to 99 beats/min
- •d) Body temperature (axilla) ranging from 35.0 to 37.4
- •(5) Judged to be healthy by the investigator based on the examination findings (subjective symptoms and objective findings), blood pressure, pulse rate, body temperature, 12-lead ECG, and laboratory tests (hematology test, biochemistry test, coagulation test, and urinalysis) at the time of screening tests
排除标准
- •(1) Accompanying diseases considered inappropriate for participation in this study including hepatic diseases, renal diseases, gastrointestinal diseases, cardiovascular diseases, hematologic diseases, respiratory diseases, immunologic or allergic diseases, neurological or psychiatric diseases, metabolic or endocrinological diseases, or malignant tumors, or a history of these diseases
- •(2) Had current or previous drug abuse (including use of illicit drugs) or alcoholism
- •(3) History of hypersensitivity to any component of TAS-115
- •(4) Consumed foods or beverages containing pomegranate, pomelo, or star fruit within 7 days before study drug administration. Excessive consumption of foods or beverages containing cruciferous vegetables (e.g., kale, broccoli, watercress, collard greens, kohlrabi, Brussels sprouts, and mustard) within 7 days before study drug administration
- •(5) Consumed foods or beverages containing grapefruit or bitter orange within 14 days before study drug administration
- •(6) Consumed foods or beverages containing the St. John's Wort within 28 days before study drug administration
- •(7) Consumed foods or beverages containing fruit juices, alcohol, caffeine, and xanthine within 3days before study drug administration
结局指标
主要结局
-
PK parameters of TAS-115 (Cmax, AUClast, and AUCinf)
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesCommon variable immunodeficiencyPrimary immunodeficiency diseases (PID)Haematological DisordersISRCTN05425999Octapharma AG (Switzerland)50
招募中
不适用
Clinical pharmacy services to improve management outcomes of Chronic Kidney Disease of uncertain etiology patients undergoing hemodialysisChronic Kidney Disease of uncertain etiologySLCTR/2018/011ational Science Foundation
招募中
1 期
Clinical study on Evaluation of therapeutic effect of acupuncture on cervical spondylosis by shear wave ultrasonic elastographyCervical spondylopathyITMCTR2100004262Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital
已完成
2 期
A Clinical study on cervical spondylosis using thengaai thuruval ottradam (external therapy)CTRI/2021/02/031542Government Siddha medical college and hospital40
进行中(未招募)
3 期
Clinical study to assess how well wilate works in the regular treatment of young children with severe von Willebrand diseaseISRCTN11217735Octapharma (Austria)12
